Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer

Preeta Tyagi; Edward Chu

doi:10.1016/s1533-0028(11)70281-x

Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	189-191
Number of pages	3
Journal	Clinical colorectal cancer
Volume	6
Issue number	3
DOIs	https://doi.org/10.1016/s1533-0028(11)70281-x
State	Published - Sep 2006
Externally published	Yes

ASJC Scopus subject areas

Oncology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s1533-0028(11)70281-x

Cite this

@article{258738c2576c453c9c5d5597baab154c,

title = "Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer",

author = "Preeta Tyagi and Edward Chu",

year = "2006",

month = sep,

doi = "10.1016/s1533-0028(11)70281-x",

language = "English (US)",

volume = "6",

pages = "189--191",

journal = "Clinical colorectal cancer",

issn = "1533-0028",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer

AU - Tyagi, Preeta

AU - Chu, Edward

PY - 2006/9

Y1 - 2006/9

UR - http://www.scopus.com/inward/record.url?scp=33750170051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750170051&partnerID=8YFLogxK

U2 - 10.1016/s1533-0028(11)70281-x

DO - 10.1016/s1533-0028(11)70281-x

M3 - Article

C2 - 17026787

AN - SCOPUS:33750170051

SN - 1533-0028

VL - 6

SP - 189

EP - 191

JO - Clinical colorectal cancer

JF - Clinical colorectal cancer

IS - 3

ER -

Safety of bevacizumab with fluoropyrimidine-based regimens for first-line treatment of metastatic colorectal cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this